Common Symptoms of Prostate Cancer and How Xtandi Treatment Can Help

In its earliest stages, prostate cancer often causes no noticeable symptoms, which is why screening remains important. When symptoms do appear, they may include difficulty starting urination, frequent nighttime urination, a weak or interrupted stream, or a feeling of incomplete bladder emptying. Blood in the urine or semen may occur, and more advanced disease can cause erectile dysfunction, persistent bone or back pain, unexplained weight loss, or leg weakness related to spinal nerve compression. Persistent changes should prompt medical evaluation to determine the cause and rule out malignancy. (CDC)

Knowing when to seek medical attention is critical. Persistent urinary symptoms, hematuria, or unexplained pain may lead physicians to order PSA tests, digital rectal exams, biopsies, or imaging scans. These tools help determine whether cancer is present and how far it may have progressed, enabling more effective and timely treatment planning. (NIH)

Treatment for prostate cancer varies widely depending on the disease stage and patient-specific factors. Early-stage cancers may be managed with active surveillance, surgery, or radiation therapy. Advanced cancers often require androgen deprivation therapy to reduce testosterone, while resistant or metastatic disease may call for chemotherapy, targeted therapies, radiopharmaceuticals, or bone-modifying agents. The goal is to control cancer progression, extend survival, and maintain quality of life. (cancer.gov)

XTANDI (enzalutamide) is a key treatment option for several forms of advanced prostate cancer. It works as an androgen-receptor inhibitor, blocking testosterone and other androgens from stimulating cancer cell growth. XTANDI is approved for metastatic hormone-sensitive prostate cancer, castration-resistant prostate cancer, and nonmetastatic disease at high risk of spreading, offering an important therapy for men whose cancer progresses despite earlier treatments. (xtandi.com)

Doctors typically prescribe XTANDI once daily, and it is often paired with ongoing androgen deprivation therapy. It may be used when cancer spreads, when PSA levels continue rising, or when imaging suggests disease progression. For many men, XTANDI delays the need for chemotherapy and helps maintain disease control for longer periods, fitting flexibly into a variety of treatment strategies. (xtandi.com)

Side effects of XTANDI can range from mild to serious. Common ones include fatigue, hot flashes, muscle or joint pain, constipation or diarrhea, high blood pressure, and an increased risk of falls or fractures. More serious risks, although less frequent, include seizures or neurological conditions such as PRES. Regular monitoring is recommended, and patients should discuss their medical history and medications with their doctor to minimize risks. (xtandi.com)

Prostate cancer remains one of the most commonly diagnosed cancers in men, and treatments continue to evolve. XTANDI exemplifies the movement toward targeted therapies designed to interrupt cancer growth while preserving quality of life. For men facing advanced or treatment-resistant prostate cancer, XTANDI offers a meaningful option that should be considered carefully with a physician who understands the patient’s goals and the behavior of their disease.

---

DailyAffairsNow is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on DailyAffairsNow.